The Sonic Incytes Liver Incyte System, Assessment of Liver Fibrosis and Steatosis
NCT03957070 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 140
Last updated 2021-11-08
Summary
Evaluate the feasibility of the Liver Incyte system for liver elasticity measurement in healthy volunteers and patients with liver fibrosis. To evaluate the discriminatory ability of elasticity measurements generated by Liver Incyte for healthy volunteers versus patients with liver fibrosis in comparison to FibroScan measurements.
Conditions
- Liver Fibrosis
- Liver Steatosis
Interventions
- DEVICE
-
Liver Incyte
Ultrasound elasticity imaging
Sponsors & Collaborators
-
Sonic Incytes
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 19 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-02-01
- Primary Completion
- 2021-04-01
- Completion
- 2021-04-01
- FDA Device
- Yes
Countries
- United States
- Canada
Study Locations
More Related Trials
-
The Ameliorative Effect of C-Kit (+) Hepatic Endothelial Cells With Mertk Deficiency on Nonalcoholic Steatohepatitis
NCT06913699 ·Status: ACTIVE_NOT_RECRUITING
-
The Use of Fibroscan to Assess Liver Fibrosis in Patients With Cardiac Pacemakers
NCT02415348 ·Status: UNKNOWN ·Phase: NA
-
Validation Study of the Velacur System in Comparison to MRE & MRI-PDFF in Patients With (Suspected) Liver Disease
NCT05908006 ·Status: UNKNOWN
-
Validation of the LiverFASt Test and the Associated Fibrosis Staging Scores Compared to Liver Tissue Pathology Via Liver Biopsy
NCT03980912 ·Status: WITHDRAWN
-
An Observational Cohort Study Evaluating Fatty Liver Disease and Liver Fibrosis in Moderate to Severe Psoriasis
NCT02174367 ·Status: UNKNOWN
-
Alterations in Intestinal Mucosal Barrier Visualized by Confocal Laser Endomicroscopy in Liver Cirrhosis: a Pilot Trial (AMBIC)
NCT03878563 ·Status: TERMINATED
-
A Study of FG-3019 in Subjects With Liver Fibrosis Due to Chronic Hepatitis B Infection
NCT01217632 ·Status: TERMINATED ·Phase: PHASE2
-
A Study to Evaluate the Safety, Tolerability, PK, and PD Effects of AZD2389 in Participants With Liver Fibrosis and Compensated Cirrhosis.
NCT06750276 ·Status: COMPLETED ·Phase: PHASE2
-
Multiple Dose Study for a New Medication to Potentially Treat Liver Diseases
NCT06891365 ·Status: RECRUITING ·Phase: PHASE1
-
A Hepatitis B With Hepatic Steatosis Study
NCT02392598 ·Status: UNKNOWN
-
Quantifying Hepatic Mitochondrial Fluxes in Humans
NCT05305287 ·Status: RECRUITING ·Phase: PHASE4
-
Endoscopic Ultrasound Shear Wave for Liver Fibrosis in MASLD Patients: The RUMIPAMBA Trial
NCT06102980 ·Status: RECRUITING ·Phase: NA
-
Erlotinib Hydrochloride in Preventing Liver Cancer in Patients With Cirrhosis of the Liver
NCT02273362 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Evaluation of the Effectiveness of the Use of a Carnitine-Orotate Complex and Biphenyl Dimethyl Dicarboxylate in the Pathogenetic Therapy of Metabolic-associated Fatty Liver Disease: a Prospective Cohort Study
NCT06078722 ·Status: UNKNOWN
-
Study of Pharmacodynamics and Safety of DGAT2i and ACCi Coadministered in Participants With Sponsor-defined Presumed Non Alcoholic Steatohepatitis
NCT04399538 ·Status: COMPLETED ·Phase: PHASE2
-
Improving Liver Fibrosis Diagnosis in Primary Care Using FibroX AI
NCT07305324 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Effects of Empagliflozin on Fibrosis and Cirrhosis in Chronic Hepatitis B Patients
NCT05147090 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Safety, Tolerability, Pharmacokinetics and Efficacy of EYP001a in Patients With Nonalcoholic Steatohepatitis (NASH)
NCT03812029 ·Status: COMPLETED ·Phase: PHASE2
-
Prospective Cohort Assessing the Role of the Genotoxin Colibactin From Escherichia Coli B2 in the Genesis of NASH
NCT02390232 ·Status: COMPLETED
-
A Study of Experimental Medication BMS-986263 in Adults With Advanced Hepatic Fibrosis After Cure of Hepatitis C
NCT03420768 ·Status: COMPLETED ·Phase: PHASE2
-
Deciphering the Mechanisms Involved in Microbial Translocation Across the Spectrum of HCV Associated Liver Fibrosis
NCT02400216 ·Status: COMPLETED
-
Companion Protocol for ¹³C-Methacetin Breath Tests in BMS: NCT03486899, NCT03486912 Referenced Trials
NCT03611101 ·Status: COMPLETED
-
Effects Of Exenatide On Liver Biochemistry, Liver Histology And Lipid Metabolism In Patients With Fatty Liver Disease
NCT00529204 ·Status: TERMINATED ·Phase: PHASE2
-
Investigation of Synbiotic Treatment in NAFLD
NCT01680640 ·Status: COMPLETED ·Phase: NA
-
Ambulatory Liver Fat Monitoring in Patients With Non-alcoholic Fatty Liver Disease
NCT05754385 ·Status: COMPLETED ·Phase: NA